ANVS

ANVS

USD

Annovis Bio Inc. Common Stock

$1.890-0.060 (-3.077%)

Reaalajas hind

Healthcare
Biotehnoloogia
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$1.950

Kõrge

$2.029

Madal

$1.890

Maht

0.22M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

46.2M

Tööstusharu

Biotehnoloogia

Riik

United States

Kauplemisstatistika

Keskmine maht

0.60M

Börs

NYQ

Valuuta

USD

52 nädala vahemik

Madal $1.11Praegune $1.890Kõrge $8.93

Seotud uudised

GlobeNewswire

Annovis Announces $6 Million Registered Direct Offering of Common Stock

MALVERN, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases

Vaata rohkem
Annovis Announces $6 Million Registered Direct Offering of Common Stock
GlobeNewswire

Annovis Announces Novel Biomarker Data in Alzheimer's Patients Supporting Buntanetap's Potential as a Disease-Modifying Treatment

MALVERN, Pa., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE:ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases

Vaata rohkem
Annovis Announces Novel Biomarker Data in Alzheimer's Patients Supporting Buntanetap's Potential as a Disease-Modifying Treatment
GlobeNewswire

Annovis Appoints Mark Guerin as Chief Financial Officer

MALVERN, Pa., Sept. 25, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc.

Vaata rohkem
Annovis Appoints Mark Guerin as Chief Financial Officer